The most rcent announcement highlighted the production testing program (revenue positive) for RGN1, expected to be run during Q3.
Although there seemed a very low key vibe to the upcoming process in that announcement, I believe the outcome is going to be of monumental consequence.
In the run down to the AGM, from the end of Q3, presumably the outcome of the production testing is all we can cling onto as possible progress.
Meanwhile, Lets hope the farm-in proposition might rise from the watery depths.
- Forums
- ASX - By Stock
- EGO
- Lets look at a hypothesis for a Farm-in?
Lets look at a hypothesis for a Farm-in?, page-23
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online